Alzamend Neuro, Inc. (ALZN)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.19
- As of
Kresmion compiles this page from ALZN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Alzamend Neuro, Inc. (ALZN): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-29.
See the full ALZN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ALZN on one page. Preview it with sample data, then open it live with a free account.
Preview the ALZN dossierActive events for ALZN
- mediumEarnings above estimates
Q3-2026: Beat consensus by 70.5%, EPS $-0.58 vs $-1.9635 estimate
- mediumEarnings above estimates
Q4-2026: Beat consensus by 31.2%, EPS $-0.47 vs $-0.6834 estimate
- mediumEarnings above estimates
Beat consensus by 70.5%, EPS $-0.58 vs $-1.9635 estimate
- mediumEarnings above estimates
Beat consensus by 70.5% - EPS $-0.58 vs $-1.9635 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 85.0% - EPS $-0.3 vs $-1.9941 estimate
FREE, NO ACCOUNT
Every event on ALZN, as it fires
You are seeing 5 of 7 events recorded on ALZN since 2026-05-26.
The five above landed across 4 days. The other 2 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, ALZN
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
ALZN mentioned in Kresmion daily briefs
ALZN against its peers
ALZN's return on equity of -1196.4% ranks in the 2nd percentile of 19 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-04-30.
| Metric | ALZN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 88000 | n/a | 15 |
| Gross margin | n/a | 49.4% | n/a | 8 |
| Operating margin | n/a | -1942.2% | n/a | 11 |
| Net margin | n/a | -1789.8% | n/a | 12 |
| Return on equity | -1196.4% | -194.0% | 3 | 19 |
Peers (22): SKYE, CSCIF, NIKI, BGMS, VSBC, RVPH, APRE, ACXP, SNTI, AIM, LEXX, TRAW, XCUR, TCRT, OSRH, SNGX, LGVN, CELZ, AZTR, CNSP, IMRN, CURX. Left out: ENVB (no annual filing), FBLG (no annual filing), LIANY (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (ALZN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow ALZN on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to ALZN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.